| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $1.62B | +29.6% |
| Cost of Revenue | $376.5M | +26.2% |
| Gross Profit | $1.24B | +30.6% |
| R&D Expense | $344.6M | +15.0% |
| SG&A Expense | $266.3M | +13.5% |
| Operating Income | -$52.6M | +72.3% |
| Pre-tax Income | $906K | +100.6% |
| Income Tax | $10.0M | +123.1% |
| Net Income | -$9.1M | +94.1% |
| EPS (Basic) | -$0.02 | +92.9% |
| EPS (Diluted) | -$0.02 | +92.9% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $318.8M | +40.1% |
| Accounts Receivable | $321.4M | +37.4% |
| Inventory | $48.2M | +23.9% |
| Current Assets | $1.51B | +31.6% |
| Total Assets | $2.54B | +25.5% |
| Current Liabilities | $917.0M | +20.4% |
| Total Liabilities | $1.12B | +17.3% |
| Stockholders' Equity |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $236.2M | +79.4% |
| Capital Expenditures | $28.8M | +42.6% |
| Investing Cash Flow | -$189.5M | -184.5% |
| Financing Cash Flow | $29.9M | +10.4% |
| Free Cash Flow | $207.4M | +86.1% |
| $1.42B |
| +32.9% |